• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌中远处复发与第二原发肿瘤的区分 - DAHANCA 研究组对配对肿瘤样本的分析。

Separating distant recurrences from second primaries in head and neck squamous cell carcinomas - A DAHANCA group analysis on paired tumor samples.

机构信息

Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.

Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark.

出版信息

Head Neck. 2024 Oct;46(10):2532-2539. doi: 10.1002/hed.27750. Epub 2024 Mar 25.

DOI:10.1002/hed.27750
PMID:38528796
Abstract

BACKGROUND

In head and neck squamous cell carcinomas (HNSCC), there is no clinically available method to separate distant metastases (DMs) from SCC secondary primary tumors. The study aimed to assess the genetic relationship in paired tumor samples.

METHODS

Patients with pairs of solid biopsies from the primary HNSCC and suspected DMs were identified (2007-2017). Targeted next-generation sequencing of 22 genes was applied, including TP53, supplemented with human papillomavirus (HPV) genotyping.

RESULTS

Of 55 pairs obtained, 33 were successfully analyzed. Distant biopsies included lung, liver, and bone. A genetic match was found in 23/33 (70%) patients, primarily with identical TP53 mutations or HPV genotypes. In 10/33 patients (30%), the genetic relationship was absent, all with lung involvement. In patients with no lung involvement, 8/8 had a match.

CONCLUSIONS

One-third of patients with DMs in HNSCC lack a genetic relationship with the primary tumors. The risk of misclassification is most prominent for patients with lung involvement.

摘要

背景

在头颈部鳞状细胞癌(HNSCC)中,尚无临床可用的方法将远处转移(DMs)与 SCC 继发性原发性肿瘤区分开来。本研究旨在评估配对肿瘤样本中的遗传关系。

方法

确定了 2007 年至 2017 年间具有原发性 HNSCC 和疑似 DMs 的成对实体活检的患者。对 22 个基因进行了靶向下一代测序,包括 TP53,并补充了人乳头瘤病毒(HPV)基因分型。

结果

共获得 55 对,33 对成功分析。远处活检包括肺、肝和骨。在 23/33(70%)患者中发现了遗传匹配,主要是具有相同的 TP53 突变或 HPV 基因型。在 10/33 名患者(30%)中,遗传关系不存在,所有患者均有肺部受累。在无肺部受累的患者中,8/8 例均有匹配。

结论

HNSCC 中 DMs 的三分之一患者与原发性肿瘤之间不存在遗传关系。对于有肺部受累的患者,分类错误的风险最大。

相似文献

1
Separating distant recurrences from second primaries in head and neck squamous cell carcinomas - A DAHANCA group analysis on paired tumor samples. 头颈部鳞状细胞癌中远处复发与第二原发肿瘤的区分 - DAHANCA 研究组对配对肿瘤样本的分析。
Head Neck. 2024 Oct;46(10):2532-2539. doi: 10.1002/hed.27750. Epub 2024 Mar 25.
2
Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.靶向测序揭示TP53作为头颈部癌治疗后监测中的潜在诊断生物标志物。
Oncotarget. 2016 Sep 20;7(38):61575-61586. doi: 10.18632/oncotarget.11196.
3
Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.联合人乳头瘤病毒分型和 TP53 突变分析在鉴别头颈部鳞状细胞癌患者的第二原发肿瘤与肺转移瘤。
Head Neck. 2018 Jun;40(6):1109-1119. doi: 10.1002/hed.25041. Epub 2018 Mar 9.
4
Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.探讨靶向下一代测序指导头颈部鳞状细胞癌治疗的可行性。
Cancer Res Treat. 2019 Jan;51(1):300-312. doi: 10.4143/crt.2018.012. Epub 2018 May 9.
5
Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma.低 PD-L1 表达、MAP2K2 改变和 HPV 基因特征丰富的特点,构成了头颈部鳞状细胞癌脑转移的特征。
J Transl Med. 2024 Oct 22;22(1):960. doi: 10.1186/s12967-024-05761-z.
6
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.通过癌症基因靶向测序确定的头颈部鳞状细胞癌的基因组改变。
Ann Oncol. 2015 Jun;26(6):1216-1223. doi: 10.1093/annonc/mdv109. Epub 2015 Feb 23.
7
Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy.同期放化疗后局部复发头颈部癌的分子特征。
Clin Cancer Res. 2019 Dec 1;25(23):7256-7265. doi: 10.1158/1078-0432.CCR-19-0628. Epub 2019 Aug 22.
8
Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status.复发性和/或转移性口咽鳞状细胞癌中与人类乳头状瘤病毒状态相关的突变模式。
Cancer Med. 2021 Feb;10(4):1347-1356. doi: 10.1002/cam4.3741. Epub 2021 Feb 1.
9
PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.PYHIN 基因作为人乳头瘤病毒阳性或阴性头颈部鳞状细胞癌预后的潜在生物标志物。
Mol Biol Rep. 2019 Jun;46(3):3333-3347. doi: 10.1007/s11033-019-04795-7. Epub 2019 Apr 12.
10
All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma.全外显子 TP53 测序与蛋白表型分析准确预测头颈部鳞状细胞癌手术治疗后的临床结局。
Ann Surg Oncol. 2019 Jul;26(7):2294-2303. doi: 10.1245/s10434-019-07287-x. Epub 2019 Mar 21.

引用本文的文献

1
Structured Early Follow-Up in Head and Neck Squamous Cell Carcinomas: A Retrospective Cohort Study.头颈部鳞状细胞癌的结构化早期随访:一项回顾性队列研究。
Biomedicines. 2025 May 20;13(5):1246. doi: 10.3390/biomedicines13051246.